| |
Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE (July, 2004). Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide - A Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol: 2873-6.
Yang Q, Liu S, Tian Y, Hasan C, Kersey D, Salwen HR, Chlenski A, Perlman EJ, Cohn SL (July, 2004). Methylation-associated silencing of the heat shock protein 47 gene in human retinoblastoma. Cancer Res: 4531-8.
Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Columbani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882 (July, 2004). Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study - Pediatric Oncology Group 904. J Clin Concol: 2601-700.
Fukuzawa R, Breslow NE, Morison IM, Dwyer P, Kusafuka T, Kobayashi Y, Becroft DM, Beckwith JB, Perlman EJ, Reeve AE (February, 2004). Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet: 446-51.
Qualman SJ, Bowen J, Amin MB, Srigley JR, Gundy PE, Perlman EJ, Members of Cancer Committee, College of American Pathologists (October, 2003). Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Arch Pathol Lab Med: 1280-9.
Schuster AE, Schneider DT, Fritsch MK, Grundy P, Perlman EJ (September, 2003). Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Lab Invest: 1293-9.
Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ (December, 2002). Renal medullary carcinoma: clinical, pathologic, immunohistochemical and genetic anaylsis with pathogenetic implications. Urology: 1083-9.
|